Sex-Based Genetic Switches in Immune Cells Uncovered
A groundbreaking study has identified over 1,000 genetic switches that operate differently in female and male immune cells, providing a biological basis for why women are more prone to autoimmune diseases.
The Study
Published in The American Journal of Human Genetics, the research was conducted by scientists from the Garvan Institute of Medical Research and UNSW Sydney.
The team analyzed over 1.25 million peripheral blood mononuclear cells from 982 participants (564 females and 418 males) in the OneK1K cohort. Using single-cell RNA sequencing, they examined gene activity in individual immune cells.
Key Findings
The study revealed that these genetic switches function differently in female and male immune cells, with differences detected on both sex chromosomes and autosomes (non-sex chromosomes).
Cell Type Proportions:
- Male immune cells showed higher proportions of monocytes
- Female immune cells showed higher levels of B cells and T cells
Inflammatory Pathways: Female immune cells exhibited higher activity in inflammatory pathways.
Specific Gene Variants: The team identified specific variants affecting female-biased expression of two genes, FCGR3A and ITGB2, which are linked to systemic lupus erythematosus.
Researcher Perspectives
Dr. Seyhan Yazar, first author and researcher from Garvan and UNSW's School of Clinical Medicine: "Our findings show that the immune system needs to be studied with sex in mind."
Dr. Sara Ballouz, co-senior author: "While this highly reactive immune profile gives females an advantage in fighting viral infections, it comes with a biological trade-off: a greater predisposition to autoimmune diseases."
Professor Joseph Powell, co-senior author: "Treatments need to be tailored not just to the disease, but to how a patient's immune system operates at a baseline genetic level."
Implications for Medicine
The researchers emphasized that these results underscore the need for sex-specific approaches in medical research. They proposed that treatments for conditions like lupus may need to be tailored based on how a patient's immune system functions at a baseline genetic level.